Stock & Company Details
Celcuity Inc $CELC
Price:
46,691,331
49M
$4.3B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Commercial Services
CELC technical indicators
Latest Celcuity Inc (CELC) technical indicators as of 2026-07-21: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
42.01 10.1%
MACD:
-3.36 8.5%
SMA 50:
$107.70 0.7%
SMA 200:
$102.25 0.2%
EMA 20:
$98.99 0.8%
Bollinger Bands:
119 / 83.33
Stochastic:
13.54 35.1%
ADX 14:
21.33 0.7%
ATR 14:
7.60 2.5%
CCI 20:
-88.81 8.3%
OBV:
50.74M 3.8%
ROC 12:
-15.06% 4.6%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Celcuity Inc is a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications. The company's therapeutic candidate is gedatolisib, a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all Class I isoforms of PI3K and the mammalian target of rapamycin (mTOR).
Finance Bot
Ask your questions
Start by typing a question below.
